# Transrectal MRI-Guided Biopsy in Identifying Cancer in Patients With Suspected Prostate Cancer

> **NCT02501759** · NA · TERMINATED · sponsor: **OHSU Knight Cancer Institute** · enrollment: 2 (actual)

## Conditions studied

- Health Status Unknown
- Prostate Carcinoma

## Interventions

- **PROCEDURE:** 3 Tesla Magnetic Resonance Imaging
- **RADIATION:** Gadodiamide
- **PROCEDURE:** Multiparametric Magnetic Resonance Imaging
- **PROCEDURE:** Transrectal Biopsy
- **PROCEDURE:** Ultrasound-Guided Prostate Biopsy

## Key facts

- **NCT ID:** NCT02501759
- **Lead sponsor:** OHSU Knight Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-05
- **Primary completion:** 2016-12-31
- **Final completion:** 2017-02-10
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Low enrollment and funding loss.
- **Last updated:** 2019-04-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02501759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02501759, "Transrectal MRI-Guided Biopsy in Identifying Cancer in Patients With Suspected Prostate Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02501759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*